Loh et al. showed experimentally that the DOK3 docking protein plays a key role in the pathogenesis of atopic dermatitis by inhibiting the activity of CARD11, which leads to the release of interferon IFN-γ by T cells, protecting against the development of atopic dermatitis. This evidence concerns the gene DOK3 and atopic eczema.